title: Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration.
authors: Megan
authors: M
authors: Cully
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D006801:Humans; D000069579:Ranibizumab; D014792:Visual Acuity / Q000187:drug effects* / Q000502:physiology; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab